Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |